ID: h-8254c04dfd
Hypothesis
Endosomal trafficking defects are the common upstream lesion linking APP processing and cholinergic degeneration
AD-risk trafficking defects in SORL1/BIN1/PICALM/retromer may generate parallel early outputs: amyloidogenic APP sorting and selective basal-forebrain cholinergic trophic failure.
EvidencePending (0%)📖 8 cit🗣 1 debates✓ 8 support✗ 2 oppose
✓ All Quality Gates Passed
🧪 Overview
AD-risk trafficking defects in SORL1/BIN1/PICALM/retromer may generate parallel early outputs: amyloidogenic APP sorting and selective basal-forebrain cholinergic trophic failure. This best fits the debate because it explains why temporal order can appear inconsistent across cohorts without requiring a single linear sequence.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["NTRK1/TrkA Receptor<br/>Neurotrophin Tyrosine Kinase"]
B["NGF Binding<br/>Dimerization and Autophosphorylation"]
C["PI3K/AKT Pathway<br/>Survival Signal Cascade"]
D["MAPK/ERK Pathway<br/>Neuronal Differentiation"]
E["PLCgamma1 Activation<br/>Calcium Signaling Cascade"]
F["TrkA Internalization<br/>Endosomal Signaling"]
G["Sustained AKT Signaling<br/>Pro-Survival Outcome"]
H["Tau Phosphorylation<br/>ERK-Mediated GSK3B"]
I["Neuronal Apoptosis<br/>Survival Signal Loss"]
A --> B
B --> C
B --> D
B --> E
C --> F
F --> G
D --> H
G -->|"blocks"| I
H -.->|"contributes"| I
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style I fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a⚖️ Evidence
⚖️ Evidence Matrix8 supports2 contradicts
Supports
Human genetics and experimental work converge on endosomal trafficking as a core AD vulnerability mechanism with therapeutic retromer relevance.
Supports
Recent SORL1-focused studies strengthen the link between trafficking biology and AD pathogenesis/biomarkers.
Supports
Basal forebrain cholinergic neurons are anatomically and trophically vulnerable in AD, making them plausible selective victims of transport defects.
Supports
Alzheimer's disease risk genes and mechanisms of disease pathogenesis.
Supports
Bin1 and CD2AP polarise the endocytic generation of beta-amyloid.
Supports
BIN1 in the Pursuit of Ousting the Alzheimer's Reign: Impact on Amyloid and Tau Neuropathology.
Supports
BIN1 regulates BACE1 intracellular trafficking and amyloid-β production.
Supports
Cell-type-specific regulation of APOE and CLU levels in human neurons by the Alzheimer's disease risk gene SORL1.
Contradicts
Direct proof that the same earliest trafficking lesion causes both human cholinergic dysfunction and amyloid pathology is still lacking.
Contradicts
Basal-forebrain selectivity remains incomplete; trafficking defects may affect cortical and cholinergic neurons similarly rather than establishing cholinergic-first disease.
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — SORL1
No curated PDB or AlphaFold mapping for SORL1 yet. Search RCSB →
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for SORL1, BIN1, PICALM, VPS35, APP, NTRK1 from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for SORL1, BIN1, PICALM, VPS35, APP, NTRK1.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
💰 Estimated Development
Cost
$0
Timeline
—
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↘
Falling
7d Momentum
▼ 1.2%
Volatility
Low
0.0070
Events (7d)
3
Price History
▼17.9%💾 Resource Usage
LLM Tokens
19,162
$0.0575
Total Cost
$0.0575
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF carriers of AD-risk variants in SORL1/BIN1/PICALM/VPS35 are stratified from the Mayo Clinic Study of Aging cohort, THEN cerebrospinal fluid biomarkers reflecting amyloidogenic APP processing (Aβ42/ | Significant negative correlation between reduced CSF Aβ42/40 ratio and decreased basal forebrain ChAT activity/expression in SORL1/BIN1/PICALM/VPS35 variant car | — no observation — | pending | 0.55 |
| IF endosomal trafficking function is restored (via VPS35 overexpression or SORL1 activation) in human iPSC-derived basal forebrain cholinergic neurons harboring AD-risk variants in SORL1/BIN1/PICALM/V | Simultaneous reduction in Aβ42 secretion (≥50% decrease from baseline) AND increase in ChAT activity (≥30% increase) AND restoration of NTRK1-mediated trophic s | — no observation — | pending | 0.65 |
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF endosomal trafficking function is restored (via VPS35 overexpression or SORL1 activation) in human iPSC-derived basal forebrain cholinergic neurons harboring AD-risk variants in SORL1/BIN1/PICALM/VPS35, THEN both amyloidogenic APP processing (Aβ42 secretion) and cholinergic viability markers (ChA
Predicted outcome: Simultaneous reduction in Aβ42 secretion (≥50% decrease from baseline) AND increase in ChAT activity (≥30% increase) AND restoration of NTRK1-mediated
Falsification: Rescue of endosomal trafficking normalizes amyloidogenic APP processing but does NOT improve cholinergic markers (ChAT activity remains decreased and/or NTRK1 signaling remains impaired), indicating i
pendingconf 55%
IF carriers of AD-risk variants in SORL1/BIN1/PICALM/VPS35 are stratified from the Mayo Clinic Study of Aging cohort, THEN cerebrospinal fluid biomarkers reflecting amyloidogenic APP processing (Aβ42/40 ratio) and cholinergic integrity (ChAT activity or ChAT gene expression in postmortem basal foreb
Predicted outcome: Significant negative correlation between reduced CSF Aβ42/40 ratio and decreased basal forebrain ChAT activity/expression in SORL1/BIN1/PICALM/VPS35 v
Falsification: AD-risk variant carriers show impaired amyloidogenic APP processing OR cholinergic dysfunction, but these impairments are UNCORRELATED (r > -0.20 or p > 0.05), indicating separable upstream lesions ra
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.